ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pomalidomide Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39I9404
Home | Market Reports | Health| Pharmacy
Global Pomalidomide Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pomalidomide Market Research Report 2025

Code: QYRE-Auto-39I9404
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla Ltd
Glenmark Pharmaceuticals
Dr. Reddy’s Laboratories
Qilu Pharmaceutical
Chia Tai Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM

Pomalidomide Market

The global market for Pomalidomide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pomalidomide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pomalidomide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pomalidomide include Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, Glenmark Pharmaceuticals, Dr Reddy's Laboratories, Qilu Pharmaceutical, Chia Tai-Tianqing, Hanson Pharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pomalidomide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pomalidomide.
The Pomalidomide market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pomalidomide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pomalidomide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pomalidomide Market Report

Report Metric Details
Report Name Pomalidomide Market
Segment by Type
  • 1mg Tables
  • 2mg Tables
  • 4mg Tables
Segment by Application
  • Hospital
  • Drug Center
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, Glenmark Pharmaceuticals, Dr Reddy's Laboratories, Qilu Pharmaceutical, Chia Tai-Tianqing, Hanson Pharm, Meidakang Huakang Pharmaceutical, Shandong Kongfu Pharmaceutical, SL PHARM
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pomalidomide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pomalidomide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pomalidomide Market report?

Ans: The main players in the Pomalidomide Market are Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, Glenmark Pharmaceuticals, Dr Reddy's Laboratories, Qilu Pharmaceutical, Chia Tai-Tianqing, Hanson Pharm, Meidakang Huakang Pharmaceutical, Shandong Kongfu Pharmaceutical, SL PHARM

What are the Application segmentation covered in the Pomalidomide Market report?

Ans: The Applications covered in the Pomalidomide Market report are Hospital, Drug Center, Clinic, Others

What are the Type segmentation covered in the Pomalidomide Market report?

Ans: The Types covered in the Pomalidomide Market report are 1mg Tables, 2mg Tables, 4mg Tables

1 Pomalidomide Market Overview
1.1 Product Definition
1.2 Pomalidomide by Type
1.2.1 Global Pomalidomide Market Value Comparison by Type (2024 VS 2031)
1.2.2 1mg Tables
1.2.3 2mg Tables
1.2.4 4mg Tables
1.3 Pomalidomide by Application
1.3.1 Global Pomalidomide Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Center
1.3.4 Clinic
1.3.5 Others
1.4 Global Pomalidomide Market Size Estimates and Forecasts
1.4.1 Global Pomalidomide Revenue 2020-2031
1.4.2 Global Pomalidomide Sales 2020-2031
1.4.3 Global Pomalidomide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pomalidomide Market Competition by Manufacturers
2.1 Global Pomalidomide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pomalidomide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pomalidomide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pomalidomide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pomalidomide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pomalidomide, Product Type & Application
2.7 Global Key Manufacturers of Pomalidomide, Date of Enter into This Industry
2.8 Global Pomalidomide Market Competitive Situation and Trends
2.8.1 Global Pomalidomide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pomalidomide Players Market Share by Revenue
2.8.3 Global Pomalidomide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pomalidomide Market Scenario by Region
3.1 Global Pomalidomide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pomalidomide Sales by Region: 2020-2031
3.2.1 Global Pomalidomide Sales by Region: 2020-2025
3.2.2 Global Pomalidomide Sales by Region: 2026-2031
3.3 Global Pomalidomide Revenue by Region: 2020-2031
3.3.1 Global Pomalidomide Revenue by Region: 2020-2025
3.3.2 Global Pomalidomide Revenue by Region: 2026-2031
3.4 North America Pomalidomide Market Facts & Figures by Country
3.4.1 North America Pomalidomide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pomalidomide Sales by Country (2020-2031)
3.4.3 North America Pomalidomide Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pomalidomide Market Facts & Figures by Country
3.5.1 Europe Pomalidomide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pomalidomide Sales by Country (2020-2031)
3.5.3 Europe Pomalidomide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pomalidomide Market Facts & Figures by Region
3.6.1 Asia Pacific Pomalidomide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pomalidomide Sales by Region (2020-2031)
3.6.3 Asia Pacific Pomalidomide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pomalidomide Market Facts & Figures by Country
3.7.1 Latin America Pomalidomide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pomalidomide Sales by Country (2020-2031)
3.7.3 Latin America Pomalidomide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pomalidomide Market Facts & Figures by Country
3.8.1 Middle East and Africa Pomalidomide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pomalidomide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pomalidomide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pomalidomide Sales by Type (2020-2031)
4.1.1 Global Pomalidomide Sales by Type (2020-2025)
4.1.2 Global Pomalidomide Sales by Type (2026-2031)
4.1.3 Global Pomalidomide Sales Market Share by Type (2020-2031)
4.2 Global Pomalidomide Revenue by Type (2020-2031)
4.2.1 Global Pomalidomide Revenue by Type (2020-2025)
4.2.2 Global Pomalidomide Revenue by Type (2026-2031)
4.2.3 Global Pomalidomide Revenue Market Share by Type (2020-2031)
4.3 Global Pomalidomide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pomalidomide Sales by Application (2020-2031)
5.1.1 Global Pomalidomide Sales by Application (2020-2025)
5.1.2 Global Pomalidomide Sales by Application (2026-2031)
5.1.3 Global Pomalidomide Sales Market Share by Application (2020-2031)
5.2 Global Pomalidomide Revenue by Application (2020-2031)
5.2.1 Global Pomalidomide Revenue by Application (2020-2025)
5.2.2 Global Pomalidomide Revenue by Application (2026-2031)
5.2.3 Global Pomalidomide Revenue Market Share by Application (2020-2031)
5.3 Global Pomalidomide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Company Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Celgene Pomalidomide Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 Natco Pharma
6.2.1 Natco Pharma Company Information
6.2.2 Natco Pharma Description and Business Overview
6.2.3 Natco Pharma Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Natco Pharma Pomalidomide Product Portfolio
6.2.5 Natco Pharma Recent Developments/Updates
6.3 Intas Pharmaceuticals
6.3.1 Intas Pharmaceuticals Company Information
6.3.2 Intas Pharmaceuticals Description and Business Overview
6.3.3 Intas Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Intas Pharmaceuticals Pomalidomide Product Portfolio
6.3.5 Intas Pharmaceuticals Recent Developments/Updates
6.4 Indiabulls Pharmaceutical
6.4.1 Indiabulls Pharmaceutical Company Information
6.4.2 Indiabulls Pharmaceutical Description and Business Overview
6.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Indiabulls Pharmaceutical Pomalidomide Product Portfolio
6.4.5 Indiabulls Pharmaceutical Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cipla Pomalidomide Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Glenmark Pharmaceuticals
6.6.1 Glenmark Pharmaceuticals Company Information
6.6.2 Glenmark Pharmaceuticals Description and Business Overview
6.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Glenmark Pharmaceuticals Pomalidomide Product Portfolio
6.6.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.7 Dr Reddy's Laboratories
6.7.1 Dr Reddy's Laboratories Company Information
6.7.2 Dr Reddy's Laboratories Description and Business Overview
6.7.3 Dr Reddy's Laboratories Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dr Reddy's Laboratories Pomalidomide Product Portfolio
6.7.5 Dr Reddy's Laboratories Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Company Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qilu Pharmaceutical Pomalidomide Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Chia Tai-Tianqing
6.9.1 Chia Tai-Tianqing Company Information
6.9.2 Chia Tai-Tianqing Description and Business Overview
6.9.3 Chia Tai-Tianqing Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Chia Tai-Tianqing Pomalidomide Product Portfolio
6.9.5 Chia Tai-Tianqing Recent Developments/Updates
6.10 Hanson Pharm
6.10.1 Hanson Pharm Company Information
6.10.2 Hanson Pharm Description and Business Overview
6.10.3 Hanson Pharm Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hanson Pharm Pomalidomide Product Portfolio
6.10.5 Hanson Pharm Recent Developments/Updates
6.11 Meidakang Huakang Pharmaceutical
6.11.1 Meidakang Huakang Pharmaceutical Company Information
6.11.2 Meidakang Huakang Pharmaceutical Description and Business Overview
6.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolio
6.11.5 Meidakang Huakang Pharmaceutical Recent Developments/Updates
6.12 Shandong Kongfu Pharmaceutical
6.12.1 Shandong Kongfu Pharmaceutical Company Information
6.12.2 Shandong Kongfu Pharmaceutical Description and Business Overview
6.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolio
6.12.5 Shandong Kongfu Pharmaceutical Recent Developments/Updates
6.13 SL PHARM
6.13.1 SL PHARM Company Information
6.13.2 SL PHARM Description and Business Overview
6.13.3 SL PHARM Pomalidomide Sales, Revenue and Gross Margin (2020-2025)
6.13.4 SL PHARM Pomalidomide Product Portfolio
6.13.5 SL PHARM Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pomalidomide Industry Chain Analysis
7.2 Pomalidomide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pomalidomide Production Mode & Process Analysis
7.4 Pomalidomide Sales and Marketing
7.4.1 Pomalidomide Sales Channels
7.4.2 Pomalidomide Distributors
7.5 Pomalidomide Customer Analysis
8 Pomalidomide Market Dynamics
8.1 Pomalidomide Industry Trends
8.2 Pomalidomide Market Drivers
8.3 Pomalidomide Market Challenges
8.4 Pomalidomide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Celgene
Natco Pharma
Intas Pharmaceuticals
Indiabulls Pharmaceutical
Cipla Ltd
Glenmark Pharmaceuticals
Dr. Reddy’s Laboratories
Qilu Pharmaceutical
Chia Tai Tianqing
Hanson Pharm
Meidakang Huakang Pharmaceutical
Shandong Kongfu Pharmaceutical
SL PHARM
List of Tables
 Table 1. Global Pomalidomide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pomalidomide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pomalidomide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pomalidomide Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Pomalidomide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pomalidomide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pomalidomide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pomalidomide Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pomalidomide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pomalidomide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pomalidomide, Product Type & Application
 Table 12. Global Key Manufacturers of Pomalidomide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pomalidomide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pomalidomide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pomalidomide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pomalidomide Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Pomalidomide Sales Market Share by Region (2020-2025)
 Table 19. Global Pomalidomide Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Pomalidomide Sales Market Share by Region (2026-2031)
 Table 21. Global Pomalidomide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pomalidomide Revenue Market Share by Region (2020-2025)
 Table 23. Global Pomalidomide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pomalidomide Revenue Market Share by Region (2026-2031)
 Table 25. North America Pomalidomide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pomalidomide Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Pomalidomide Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Pomalidomide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pomalidomide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pomalidomide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pomalidomide Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Pomalidomide Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Pomalidomide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pomalidomide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pomalidomide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pomalidomide Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Pomalidomide Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Pomalidomide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pomalidomide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pomalidomide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pomalidomide Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Pomalidomide Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Pomalidomide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pomalidomide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pomalidomide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pomalidomide Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Pomalidomide Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Pomalidomide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pomalidomide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pomalidomide Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Pomalidomide Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Pomalidomide Sales Market Share by Type (2020-2025)
 Table 53. Global Pomalidomide Sales Market Share by Type (2026-2031)
 Table 54. Global Pomalidomide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pomalidomide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pomalidomide Revenue Market Share by Type (2020-2025)
 Table 57. Global Pomalidomide Revenue Market Share by Type (2026-2031)
 Table 58. Global Pomalidomide Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Pomalidomide Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Pomalidomide Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Pomalidomide Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Pomalidomide Sales Market Share by Application (2020-2025)
 Table 63. Global Pomalidomide Sales Market Share by Application (2026-2031)
 Table 64. Global Pomalidomide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pomalidomide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pomalidomide Revenue Market Share by Application (2020-2025)
 Table 67. Global Pomalidomide Revenue Market Share by Application (2026-2031)
 Table 68. Global Pomalidomide Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Pomalidomide Price (USD/Pcs) by Application (2026-2031)
 Table 70. Celgene Company Information
 Table 71. Celgene Description and Business Overview
 Table 72. Celgene Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Celgene Pomalidomide Product
 Table 74. Celgene Recent Developments/Updates
 Table 75. Natco Pharma Company Information
 Table 76. Natco Pharma Description and Business Overview
 Table 77. Natco Pharma Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Natco Pharma Pomalidomide Product
 Table 79. Natco Pharma Recent Developments/Updates
 Table 80. Intas Pharmaceuticals Company Information
 Table 81. Intas Pharmaceuticals Description and Business Overview
 Table 82. Intas Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Intas Pharmaceuticals Pomalidomide Product
 Table 84. Intas Pharmaceuticals Recent Developments/Updates
 Table 85. Indiabulls Pharmaceutical Company Information
 Table 86. Indiabulls Pharmaceutical Description and Business Overview
 Table 87. Indiabulls Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Indiabulls Pharmaceutical Pomalidomide Product
 Table 89. Indiabulls Pharmaceutical Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Cipla Pomalidomide Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Glenmark Pharmaceuticals Company Information
 Table 96. Glenmark Pharmaceuticals Description and Business Overview
 Table 97. Glenmark Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Glenmark Pharmaceuticals Pomalidomide Product
 Table 99. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 100. Dr Reddy's Laboratories Company Information
 Table 101. Dr Reddy's Laboratories Description and Business Overview
 Table 102. Dr Reddy's Laboratories Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Dr Reddy's Laboratories Pomalidomide Product
 Table 104. Dr Reddy's Laboratories Recent Developments/Updates
 Table 105. Qilu Pharmaceutical Company Information
 Table 106. Qilu Pharmaceutical Description and Business Overview
 Table 107. Qilu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Qilu Pharmaceutical Pomalidomide Product
 Table 109. Qilu Pharmaceutical Recent Developments/Updates
 Table 110. Chia Tai-Tianqing Company Information
 Table 111. Chia Tai-Tianqing Description and Business Overview
 Table 112. Chia Tai-Tianqing Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Chia Tai-Tianqing Pomalidomide Product
 Table 114. Chia Tai-Tianqing Recent Developments/Updates
 Table 115. Hanson Pharm Company Information
 Table 116. Hanson Pharm Description and Business Overview
 Table 117. Hanson Pharm Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Hanson Pharm Pomalidomide Product
 Table 119. Hanson Pharm Recent Developments/Updates
 Table 120. Meidakang Huakang Pharmaceutical Company Information
 Table 121. Meidakang Huakang Pharmaceutical Description and Business Overview
 Table 122. Meidakang Huakang Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Meidakang Huakang Pharmaceutical Pomalidomide Product
 Table 124. Meidakang Huakang Pharmaceutical Recent Developments/Updates
 Table 125. Shandong Kongfu Pharmaceutical Company Information
 Table 126. Shandong Kongfu Pharmaceutical Description and Business Overview
 Table 127. Shandong Kongfu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Shandong Kongfu Pharmaceutical Pomalidomide Product
 Table 129. Shandong Kongfu Pharmaceutical Recent Developments/Updates
 Table 130. SL PHARM Company Information
 Table 131. SL PHARM Description and Business Overview
 Table 132. SL PHARM Pomalidomide Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. SL PHARM Pomalidomide Product
 Table 134. SL PHARM Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Pomalidomide Distributors List
 Table 138. Pomalidomide Customers List
 Table 139. Pomalidomide Market Trends
 Table 140. Pomalidomide Market Drivers
 Table 141. Pomalidomide Market Challenges
 Table 142. Pomalidomide Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pomalidomide
 Figure 2. Global Pomalidomide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pomalidomide Market Share by Type: 2024 & 2031
 Figure 4. 1mg Tables Product Picture
 Figure 5. 2mg Tables Product Picture
 Figure 6. 4mg Tables Product Picture
 Figure 7. Global Pomalidomide Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pomalidomide Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Drug Center
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Global Pomalidomide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pomalidomide Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Pomalidomide Sales (2020-2031) & (K Pcs)
 Figure 16. Global Pomalidomide Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Pomalidomide Report Years Considered
 Figure 18. Pomalidomide Sales Share by Manufacturers in 2024
 Figure 19. Global Pomalidomide Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Pomalidomide Players: Market Share by Revenue in Pomalidomide in 2024
 Figure 21. Pomalidomide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Pomalidomide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Pomalidomide Sales Market Share by Country (2020-2031)
 Figure 24. North America Pomalidomide Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Pomalidomide Sales Market Share by Country (2020-2031)
 Figure 28. Europe Pomalidomide Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Pomalidomide Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Pomalidomide Revenue Market Share by Region (2020-2031)
 Figure 36. China Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Pomalidomide Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Pomalidomide Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Pomalidomide Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Pomalidomide Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Pomalidomide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Pomalidomide by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Pomalidomide by Type (2020-2031)
 Figure 58. Global Pomalidomide Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Pomalidomide by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Pomalidomide by Application (2020-2031)
 Figure 61. Global Pomalidomide Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Pomalidomide Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Pomalidomide API Market Research Report 2025
Global Malonamide Market Research Report 2025
Global Salicylamide Market Research Report 2024
Global Maleimide Market Research Report 2025
Global Iopromide Market Research Report 2025
Global Oleyl Palmitamide Market Research Report 2024
Global N Ethylmaleimide Market Research Report 2024
Global Proglumide Market Research Report 2024
Global Cefpiramide Market Research Report 2025
Global Pimobendan Market Research Report 2025
Global 4 Methylaminopyridine Market Research Report 2025
Global Glycinamide Hydrochloride Market Research Report 2024
Global Terizidone Market Research Report 2025
Global Meibomian Gland Disease Treatment Drugs Market Research Report 2024
Global Amivantamab Market Research Report 2024
Global Fingolimod Market Research Report 2025
Global Lacidipine Market Research Report 2024
Global Iron Isomaltoside Market Research Report 2025
Global Isomalt Market Research Report 2024
Global High Purity MDI Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions